NEXTLEVO-500 INJ

Indication listed by Intra Life

for the treatment of seizure disorders, including partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. It is often used when oral administration is not feasible, providing rapid control of seizures in adults and pediatric patients.

For pharmaceutical trade buyers, not patient or consumer sales. This record reproduces company product information, not medical advice. Current product availability and terms are confirmed by Intra Life.